{"abstract":"The Drug Enforcement Administration proposes placing two phenethylamine hallucinogens, as identified in this proposed rule, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances for one of these substances 2,5-dimethoxy-4-chloroamphetamine. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle these two specific controlled substances.","action":"Notice of proposed rulemaking.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2023/12/13/2023-27289.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"1308","title":21}],"citation":"88 FR 86278","comment_url":null,"comments_close_on":"2024-01-12","correction_of":null,"corrections":[],"dates":"Comments must be submitted electronically or postmarked on or before January 12, 2024.","disposition_notes":null,"docket_ids":["Docket No. DEA1156"],"dockets":[{"supporting_documents":[{"title":"DEA1156 Eight-Factor Review DOI DOC 102023","document_id":"DEA-2023-0168-0005"},{"title":"FINAL SIGNED ASH Letter to DEA_DOI-DOC_09.28.2020","document_id":"DEA-2023-0168-0004"}],"agency_name":"DEA","documents":[{"comment_count":149,"comment_start_date":"2023-12-13","updated_at":"2024-01-13T00:01:38.583-05:00","comment_url":"https://www.regulations.gov/commenton/DEA-2023-0168-0001","allow_late_comments":null,"id":"DEA-2023-0168-0001","comment_end_date":"2024-01-13","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":2,"id":"DEA-2023-0168","title":"Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156)"}],"document_number":"2023-27289","effective_on":null,"end_page":86284,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2023/12/13/2023-27289.xml","html_url":"https://www.federalregister.gov/documents/2023/12/13/2023-27289/schedules-of-controlled-substances-placement-of-25-dimethoxy-4-iodoamphetamine-doi-and","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2023-27289?publication_date=2023-12-13","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2023-12-13/2023-27289/mods.xml","not_received_for_publication":null,"page_length":7,"page_views":{"count":2380,"last_updated":"2026-10-22 18:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2023-12-13/pdf/2023-27289.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2023-27289.pdf?1702388723","publication_date":"2023-12-13","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2023/12/13/2023-27289.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"DEA1156 Eight-Factor Review DOI DOC 102023","document_id":"DEA-2023-0168-0005"},{"title":"FINAL SIGNED ASH Letter to DEA_DOI-DOC_09.28.2020","document_id":"DEA-2023-0168-0004"}],"comments_count":149,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2023-0168","supporting_documents_count":2,"docket_id":"DEA-2023-0168","document_id":"DEA-2023-0168-0001","regulation_id_number":null,"title":"Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156)","checked_regulationsdotgov_at":"2024-01-14T02:00:06Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":86278,"subtype":null,"title":"Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I","toc_doc":"Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I","toc_subject":"Schedules of Controlled Substances:\n","topics":["Administrative practice and procedure","Drug traffic control","Reporting and recordkeeping requirements"],"type":"Proposed Rule","volume":88}